TABLE 1.
Composition of the strain collection used to determine PI-2 distribution
| Strain source | Country | No. of isolates | Diagnosis (no. of isolates)a | Reference or source |
|---|---|---|---|---|
| PMEN | Various | 26 | ID | 24 |
| CDC | United States | 50 | ID | 6 |
| Oswaldo Cruz Foundation | Brazil | 55 | ID (27), C (28) | |
| ISS | Italy | 40 | ID (37), C (3) | |
| Swiss Tropical Institute | Ghana | 15 | ID | 17 |
| Dhaka Shishu Hospital | Bangladesh | 36 | ID | |
| Kenyan Medical Research Center | Kenya | 5 | ID | |
| Karolinska Institute | Sweden | 8 | ID | |
| Norwegian Institute of Public Health | Norway | 43 | C | 40a |
| University of Alabama | Various | 13 | ||
| Novartis | Various | 11 | ID | |
| Sanger Institute | Various | 3 | ID | www.sanger.ac.uk |
a
ID, invasive disease; C, carriage.